EV/EBITDA - Pharmaniaga Bhd (KLSE:PHARMA) - Alpha Spread
P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.395 MYR 1.28%
Market Cap: 569.3m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

92.3
Current
5.3
Median
12.5
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
92.3
=
Enterprise Value
1.4B MYR
/
EBITDA
15.1m MYR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
7.7
2-Years Forward
EV/EBITDA
7.5
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More